Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3 , Pages 173-182, September 2008

Carbon nanotubes as functional excipients for nanomedicines: I. pharmaceutical properties

  • Marianna Foldvari, PhD, DPharmSci

      Affiliations

    • School of Pharmacy, Faculty of Science, University of Waterloo, Waterloo, Ontario, Canada
    • Corresponding Author InformationCorresponding author. School of Pharmacy, Faculty of Science, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, Canada N2L 3G1.
  • ,
  • Mukasa Bagonluri, MSc

      Affiliations

    • College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Received 7 June 2007; accepted 4 April 2008. published online 12 June 2008.

Abstract 

Carbon nanotubes (CNTs) are considered potential biomedical materials because of their flexible structure and propensity for chemical functionalization. In the first part of this two-part review we focus on the properties and use of CNTs as building blocks for novel drug delivery systems, dosage forms, and biomedical substrates. Pharmaceutical excipients have been regarded as inert or nonactive components of dosage forms, but they are essential and necessary components of pharmaceutical preparations. Here we present a collection of data to initiate the description of CNTs as pharmaceutical excipients. We summarize the synthesis, purification, and analysis of CNTs related to their pharmaceutical properties and quality control. Application of CNTs in biological systems depends on their compatibility with hydrophilic environments; therefore, the solubilization of CNTs in pharmaceutical solvents is essential. Furthermore, because it is becoming increasingly important that the relevant chemical, physiochemical, and pharmaceutical properties of CNTs be identified, we have prepared a “mini-monograph” of CNTs that compiles their pertinent properties.

Key words: Carbon nanotubes (CNTs), CNT dispersion, CNT solubilization, Delivery system, Drug encapsulation, Pharmaceutical excipient

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This research was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR).

PII: S1549-9634(08)00042-7

doi:10.1016/j.nano.2008.04.002

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 4, Issue 3 , Pages 173-182, September 2008